PART 01: Executive summary
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Insomnia: An overview
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Pipeline portfolio
Examples of pipeline candidates
PART 08: Market segmentation by type of formulation
Mist formulation
PART 09: Market segmentation by symptom
Market overview
Poor-quality sleep
Difficulties with sleep onset and/or maintenance
PART 10: Geographical segmentation
Market overview
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
Competitive scenario
Market share analysis
Other prominent vendors
PART 17: Key vendor analysis
PART 18: Appendix
List of abbreviations
PART 19: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global insomnia drugs market 2014-2019 ($ billions)
Exhibit 03: Key performance indicators of global insomnia drugs market
Exhibit 04: Five forces analysis
Exhibit 05: Pipeline portfolio
Exhibit 06: Market segmentation by type of formulation
Exhibit 07: Market segmentation by symptom
Exhibit 08: Geographical segmentation 2014
Exhibit 09: Global insomnia drugs market: Key drivers
Exhibit 10: Impact of drivers
Exhibit 11: Global insomnia drugs market: Key challenges
Exhibit 12: Impact of drivers and challenges
Exhibit 13: Global insomnia drugs market: Emerging trends
Exhibit 14: Lunesta sales in North America 2011-2014 ($ millions)
Exhibit 15: Lunesta sales in Japan 2013-2014 ($ millions)
Exhibit 16: Ambien: Global sales 2011-2014 ($ millions)
Exhibit 17: Ambien sales in Western Europe 2011-2014 ($ millions)
Exhibit 18: Ambien sales in the US 2011-2014 ($ millions)
Exhibit 19: Ambien sales in emerging markets 2011-2014 ($ millions)
Exhibit 20: Ambien sales in ROW 2011-2014 ($ millions)
Exhibit 21: Rozerem: Global sales 2011-2013 ($ millions)
Exhibit 22: Rozerem sales in Japan 2012-2014 ($ millions)
Exhibit 23: Takeda: Business segmentation by revenue 2015
Exhibit 24: Takeda: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 25: Takeda: Geographical segmentation by revenue 2015